These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3141551)

  • 1. Intra- and extravascular turnover of thyrotrophin-releasing hormone in normal man.
    Iversen E
    J Endocrinol; 1988 Sep; 118(3):511-6. PubMed ID: 3141551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of thyrotrophin-releasing hormone in patients in different thyroid states.
    Iversen E
    J Endocrinol; 1991 Jan; 128(1):153-9. PubMed ID: 1900321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turnover of thyrotropin-releasing hormone in patients with chronic renal failure and chronic alcoholic liver disease.
    Iversen E; Schmitz O; Laurberg P
    Acta Endocrinol (Copenh); 1990 Aug; 123(2):179-84. PubMed ID: 2120878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma clearance and plasma half-disappearance time of exogenous thyrotropin-releasing hormone and pyroglutamyl-N3im-methyl-histidyl prolineamide.
    Morley JE; Garvin TJ; Pekary AE; Utiger RD; Nair MG; Baugh CM; Hershman JM
    J Clin Endocrinol Metab; 1979 Mar; 48(3):377-80. PubMed ID: 107180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics and pharmacodynamics of protirelin (TRH) in man].
    Duntas L; Keck FS; Loos U; Pfeiffer EF
    Dtsch Med Wochenschr; 1988 Sep; 113(35):1354-7. PubMed ID: 3137012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans.
    Bassiri RM; Utiger RD
    J Clin Invest; 1973 Jul; 52(7):1616-9. PubMed ID: 4198107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of thyrotropin-releasing hormone (TRH) and deamido-TRH in the rat.
    Safran M; Wu CF; Matys R; Alex S; Emerson CH
    Endocrinology; 1984 Sep; 115(3):1031-7. PubMed ID: 6430680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of exogenous thyrotropin-releasing hormone (TRH) in normal subjects: relationship to endocrine and behavioral effects.
    Loosen PT; Youngblood W; Dew B
    Pharmacopsychiatry; 1985 Nov; 18(6):325-9. PubMed ID: 3937164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin-releasing hormone: pharmacokinetic and pharmacodynamic properties in chronic renal failure.
    Duntas L; Wolf CF; Keck FS; Rosenthal J
    Clin Nephrol; 1992 Oct; 38(4):214-8. PubMed ID: 1424308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin-releasing hormone degradation in patients with insulin dependent diabetes mellitus. Effects of metabolic control.
    Duntas L; Keck FS; Wolf C; Hauner H; Pfeiffer EF
    Thyroidology; 1991 May; 3(2):51-7. PubMed ID: 1726900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of the TRH-like peptide pyroglutamyl-glutamyl-prolineamide in rats.
    Klootwijk W; de Boer RD; Sleddens-Linkels E; Cockle SM; de Herder WW; Bauer K; Visser TJ; de Greef WJ
    J Endocrinol; 1997 Jun; 153(3):411-21. PubMed ID: 9203995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-relationships between the secretory dynamics of thyrotrophin-releasing hormone, thyrotrophin and prolactin in periovulatory mares: effect of hypothyroidism.
    Alexander SL; Irvine CH; Evans MJ
    J Neuroendocrinol; 2004 Nov; 16(11):906-15. PubMed ID: 15584931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRH pharmacokinetics and nerve stimulation evoked prostatic fluid secretion during TRH infusion in the dog.
    Liberman C; Nogimori T; Wu CF; Van Buren T; Wilson J; Miller T; Smith E; Emerson CH
    Acta Endocrinol (Copenh); 1989 Feb; 120(2):134-42. PubMed ID: 2492705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance and identification of thyrotrophin releasing hormone in human urine after intravenous injections.
    Jeffcoate SL; White N
    Clin Endocrinol (Oxf); 1975 Jul; 4(4):421-6. PubMed ID: 807440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time mode of growth hormone (GH) entry into the bloodstream and steady-state plasma GH concentrations, rather than sex, estradiol, or menstrual cycle stage, primarily determine the GH elimination rate in healthy young women and men.
    Shah N; Aloi J; Evans WS; Veldhuis JD
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2862-9. PubMed ID: 10443692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the prolactin response to thyrotropin-releasing hormone (TRH) during the menstrual cycle of normal women.
    Boyd AE; Sanchez-Franco F
    J Clin Endocrinol Metab; 1977 May; 44(5):985-9. PubMed ID: 404311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The developmental pattern of thyrotropin-releasing hormone-degrading activity in the plasma of rats.
    Neary JT; Kieffer JD; Nakamura C; Mover H; Soodak M; Maloof F
    Endocrinology; 1978 Nov; 103(5):1849-54. PubMed ID: 107022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower levels of thyrotropin-releasing hormone-degrading activity in human cord and in maternal sera than in the serum of euthyroid, nonpregnant adults.
    Neary JT; Nakamura C; Davies IJ; Soodak M; Maloof F
    J Clin Invest; 1978 Jul; 62(1):1-5. PubMed ID: 96140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.